跳至主要内容
临床试验/NCT00697489
NCT00697489撤回4 期

Pelvic Organ Prolapse Correction Plus Preventive Treatment of Urinary Stress Incontinence vs. Correction of Pelvic Organ Prolapse Followed by Treatment of Urinary Stress Incontinence

University Magna Graecia2 个研究点 分布在 1 个国家开始时间: 2008年6月1日最近更新:
适应症

试验速览

阶段
4 期
状态
撤回
发起方
试验地点
2
主要终点
efficacy (cure rate)

研究概览

简要总结

The incidence of pelvic organ prolapse (POP) in parous women is estimated over 50%. A variety of urinary, bowel and sexual symptoms may be associated with POP. Moreover, a proportion of women who underwent a surgical correction of POP may occur post-surgical urinary incontinence and, thus, if this last presents as genuine stress-type or mixed-type, a second surgical intervention may be required. At this proposal, with the aim to reduce the incidence of postoperative urinary incontinence, the addition of a preventive continence procedure to a POP repair intervention has been widely proposed, but the potential benefits needs to be balanced against potential disadvantages.

Based on these considerations, the aim of this trial will be to compare two different surgical strategies for women with POP without urinary stress incontinence. Specifically, the efficacy to associate and to follow a preventive continence procedure to the correction of POP will be compared.

详细描述

Women with POP not associated to urinary stress incontinence will be enrolled and randomized in two arms(groups A and B). Patients of group A will be treated with unique surgery (correction of POP plus preventive continence procedure), whereas in patients of group B POP will be surgically corrected and, in case of stress or mixed postoperative incontinence, a further intervention for urinary stress incontinence will be tailored.

All patients eligible will undergo baseline assessment consisting of anthropometric, clinical, hormonal, ultrasonographic and urodynamic evaluations. During the study, the clinical outcomes, and the adverse experience will be evaluated in each patient.

Data will be analyzed using the intention-to-treat principle and a P value of 0.05 or less will be considered significant.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Pelvic organ prolapse stage 2-3
  • Absence of subjective urinary stress incontinence

排除标准

  • pregnancy
  • <12 months postpartum
  • systemic disease known to affect bladder function
  • current chemotherapy or radiation therapy
  • urethral diverticulum, augmentation cytoplasty, or artificial sphincter
  • recent pelvic surgery
  • patient age under 18 and over 80
  • any previous pelvic surgery, diabetes mellitus and collagen disease

结局指标

主要结局

efficacy (cure rate)

时间窗: 12 months

次要结局

  • quality of life(12 months)
  • Failure rate(12 months)
  • Recurrence rate(12 months)
  • postoperative complications rate(12 months)
  • sexual function(12 months)
  • intra-operative complication rate(one day)

研究者

发起方
University Magna Graecia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Stefano Palomba

Associate Professor

University Magna Graecia

研究点 (2)

Loading locations...

相似试验